secwatch.observer — SEC 8-K summary
======================================

Issuer:     PTC THERAPEUTICS, INC. (PTCT)
CIK:        0001070081
Form:       8-K
Filed at:   2026-06-05T21:15:21+00:00
Accession:  0001104659-26-071040
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

PTC Therapeutics shareholders elect four Class I directors and ratify Ernst & Young
--------------------------------------------------------------------------------

- Jessica Chutter, Matthew Klein, Stephanie Okey, and Jerome Zeldis elected Class I directors with >83% of votes cast.
- Ernst & Young LLP ratified as independent auditor for FY 2026 with 76.2M for, 0.4M against.
- Say-on-pay advisory proposal approved with 71.2M for, 1.5M against, 3.9M broker non-votes.
- Annual meeting held June 2, 2026; 82.9M shares outstanding as of April 10, 2026 record date.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1070081/000110465926071040/0001104659-26-071040-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1070081/000110465926071040/tmb-20260602x8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-071040

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer